Lynne Bui - 07 Nov 2022 Form 4 Insider Report for Tharimmune, Inc. (THAR)

Role
Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Lynne Bui
Issuer symbol
THAR
Transactions as of
07 Nov 2022
Transactions value $
$0
Form type
4
Date filed
09 Nov 2023, 19:55
Previous filing
23 Mar 2022
Next filing
12 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THAR Options (right to buy) Award $0 +25K $0.00 25K 07 Nov 2023 Common stock 25K $0.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.